Posted by Michael Wonder on 25 Mar 2020
FDA announces funding opportunity to explore the use of real-world data to generate real-world evidence in regulatory decision making
25 March 2020 - The U.S. Food and Drug Administration is announcing a funding opportunity for projects to support the agency’s understanding of the potential use of real-world data to generate real-world evidence.
Through this announcement, the agency hopes to encourage innovative approaches to further explore the use of RWD while making sure that scientific evidence supporting marketing approvals meet our high evidentiary standards.
FDA is particularly interested in projects that compare use of real world data and generation of real world evidence with more traditional approaches and methods for data collection and evidence generation.
